In vitro assessment of the impact of 30 CYP2C19 variants on citalopram metabolism
Background CYP2C19 polymorphisms are correlated with individual variability in response to citalopram treatment. The pharmacogenomic testing of CYP2C19 has been shown to optimize the safety and efficacy of citalopram medication. Exploration of the effect of novel CYP2C19 variants on citalopram could...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
PeerJ Inc.
2025-09-01
|
| Rangatū: | PeerJ |
| Ngā marau: | |
| Urunga tuihono: | https://peerj.com/articles/20027.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|